Search Results

The advanced Pedestrian Legform Impactor (aPLI) incorporates a number of enhancements for improved lower limb injury prediction capability with respect to its predecessor, the FlexPLI. The aPLI also incorporates a simplified upper body part (SUBP), connected to the lower limb via a mechanical hip joint, that expands the impactor’s applicability to evaluate pedestrian’s lower limb injury risk also in high-bumper cars.As the aPLI has been developed to be used in standardized testing, further considerations on the impactor’s manufacturability, robustness, durability, usability, and repeatability need to be accounted for.. The aim of this study is to define and verify, by means of numerical analysis, a battery of design modifications that may simplify the manufacturing and use of physical aPLIs, without reducing the impactors’ biofidelity. Eight candidate parameters were investigated in a two-step numerical analysis.

Current legform impact test methods using the FlexPLI have been developed to protect pedestrians from lower limb injuries in collisions with low-bumper vehicles. For this type of vehicles, the influence of the upper body on the bending load generated in the lower limb is compensated by setting the impact height of the FlexPLI 50 mm above that of pedestrians. However, neither the effectiveness of the compensation method of the FlexPLI nor the influence of the upper body on the bending load generated in the lower limb of a pedestrian has been clarified with high-bumper vehicles. In this study, therefore, two computer simulation analyses were conducted in order to analyze: (1) The influence of the upper body on the bending load generated in the lower limb of a pedestrian when impacted by high-bumper vehicles and (2) The effectiveness of the compensation method for the lack of the upper body by increasing impact height of the FlexPLI for high-bumper vehicles.

JAMA-JARI has developed a biofidelic flexible pedestrian leg-form impactor (Flex-PLI 2004) by making several modifications to the Flex-PLI 2003 to improve usability, durability and biofidelity. Biofidelity evaluation for the Flex-PLI 2004 was estimated at the component level (thigh, knee, and leg individually) as well as at the assembly level (thigh-knee-leg complex), using an objective impactor biofidelity evaluation system based on a method developed by Rhule et al. to eliminate any subjective prejudice in an impactor biofidelity evaluation. Applying the biofidelity evaluation system to the Flex-PLI 2004, the average impactor biofidelity rank (IBR) score became 1.22 at the component level and 1.26 at the assembly level. These IBR scores mean that the Flex-PLI 2004 has good biofidelity at the component level as well as at the assembly level.